Skip to main content
NCBI home page
Cytotechnology logoLink to Cytotechnology
. 1997 Nov;25(1-3):145–154. doi: 10.1023/A:1007943228587

Further investigation of the light chain shifting phenomenon: Light chain replacement through secondary rearrangement induced by lectin stimulation in the hybridoma cell line HB4C5

Chatchadaporn Krungkasem, Kyoko Ueda, Hirofumi Tachibana, Sanetaka Shirahata
PMCID: PMC3466735  PMID: 9474807

Abstract

We found that when the hybridoma cell line HB4C5 was stimulated with wheat germ agglutinin (WGA), loss of production of the original λ light chain occurred, followed by production of new light chain, which mirrored the reaction when stimulated with concanavalin A (ConA). We previously reported that the RAG genes are expressed not only in HB4C5 and its ConA-treated variant subclones, but also in the in the parental Namalwa cells, which are known to be in the plasma state. However, the new λ light chains were expressed only in the HB4C5 cells and not in the parental Namalwa cells. Here we found that the RAG genes are expressed in HB4C5 cells after continuous stimulation with WGA. To further investigate the mechanism of this loss of original λ light chain production by stimulation with lectins in HB4C5 cells, which leads to a sIg-negative subpopulation, we analyzed the differences between HB4C5 and Namalwa cells. In this present study, we found that a 70 kDa phosphorylated protein in HB4C5 cells became undetectable after stimulation with lectins (WGA and ConA), and was not detected in Namalwa cells before or after lectin stimulation. It has been believed that the RAG genes and loss of original λ light chain production are required to induce expression of a new λ light chain in the HB4C5 cells. We suggested that the phosphorylated 70 kDa protein in HB4C5 cells play important roles in regulating the production of new λ light chains which is induced by lectins.

Keywords: allelic exclusion, human plasma cells, immunoglobulin, λ light chain, lectin, rearrangement, serine phosphorylation

Full Text

The Full Text of this article is available as a PDF (166.5 KB).

References

  1. Abe T, Tsuge I, Kamachi Y, Torii S, Utsumi K, Akahori Y, Ichihara Y, Kurosawa Y, Matsuoka H. Evidence for defects in V(D)J rearrangement in patients with severe combined immunodeficiency. J Immunol. 1994;152:5504–5513. [PubMed] [Google Scholar]
  2. Bothwell A, Paskind M, Reth M, Imanish-Kari T, Rajewsky K, Baltimore D. Heavy chain variable region contribution to the Npb family of antitodies: Somatic mutation evident in a γ2a variable region. Cell. 1981;24:625–637. doi: 10.1016/0092-8674(81)90089-1. [DOI] [PubMed] [Google Scholar]
  3. Cambier J, Justement L, Newell K, Chen Z, Harris L, Sandoval V, Klemsz M, Ransam J. Transmembrane signals and intracellular ‘second messengers’ in the regulation of quiescent B lymphocyte activation. Immunol Rev. 1987;95:37–42. doi: 10.1111/j.1600-065X.1987.tb00499.x. [DOI] [PubMed] [Google Scholar]
  4. Chen Z, Coggeshall K, Cambier J. Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes. J Immunol. 1986;136:2300–2304. [PubMed] [Google Scholar]
  5. Feddersen R, Martin D, Van Ness D. The frequency of multiple recombination events occurring at the human IgκL chain locus. J Immunol. 1990;144:1088–1093. [PubMed] [Google Scholar]
  6. Goldstein I, Hollerman C, Smith E. Protein-carbohydrate interaction II, inhibition studies on the interaction of concanavalin A with polysaccharides. Biochemistry. 1965;4:876–883. doi: 10.1021/bi00881a013. [DOI] [PubMed] [Google Scholar]
  7. Hesketh R, Moore T, Pennington S, Smith G, Metcalfe J. Analysis of the primary signals required for activation of the mitogenic pathway in murine thymocytes from protein phosphorylation patteins. J Immunol. 1990;145:2571–2580. [PubMed] [Google Scholar]
  8. Kato T, Kokuho T, Tamura T, Nariuchi H. Mechanisms of T cell contact-dependent B cell activation. J Immunol. 1994;152:2130–2138. [PubMed] [Google Scholar]
  9. Kitamura D, Rajewsky K. Targeted disruption of M chain membrane exon causes loss of heavy-chain allelic exclusion. Nature. 1992;356:154–156. doi: 10.1038/356154a0. [DOI] [PubMed] [Google Scholar]
  10. Krungkasem C, Tachibana H and Shirahata S (1997) Indentification of an antibody-secreting human B cell line undergoing ‘light chain shifting’. Animal cell technology: Basic and applied aspects Vol. 8, K Funatsu et al. (eds.) pp. 639–643, Kluwer Academic Press.
  11. Larrick J, Danielsson L, Brenner C, Wallace E, Abrahamson M, Fry K, Borrebaeck C. Polymerase chain reaction using mixed primers: cloning of human monoclonal antibody variable region genes from single hybridoma cells. Biotechnology. 1989;7:934–938. doi: 10.1038/nbt0989-934. [DOI] [Google Scholar]
  12. Lewis S, Rosenberg N, Alt F, Baltimore D. Continuing kappa-gene reanangement in a cell line transformed by Abelson murine leukemia virus. Cell. 1982;30:807–816. doi: 10.1016/0092-8674(82)90285-9. [DOI] [PubMed] [Google Scholar]
  13. Ma A, Fisher, Dildrop R, Oltz E, Rathbun G, Achacoso P, Stall A, Alt F. Surface IgM mediated regulation of RAG gene expression in Eμ-N-myc B cell lines. EMBO J. 1992;11:2727–2734. doi: 10.1002/j.1460-2075.1992.tb05338.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Manz J, Denis K, Witte O, Brinster R, Storb U. Feedback inhibition of immunoglobulin gene rearrangement membrane μ, but not secreted μ heavy chain. J Exp Med. 1988;168:1363–1381. doi: 10.1084/jem.168.4.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Maxam A, Gilbert W. Sequence end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65:499–560. doi: 10.1016/S0076-6879(80)65059-9. [DOI] [PubMed] [Google Scholar]
  16. Mitchell P, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989;245:371–378. doi: 10.1126/science.2667136. [DOI] [PubMed] [Google Scholar]
  17. Murakami H, Masui H, Sato G, Sueoka N, Chow T, Kano-Sueoka T. Growth of hybridoma cells in serum-free medium: Ethanolamine is an essential component. Proc Natl Acad Sci USA. 1982;79:1158–1162. doi: 10.1073/pnas.79.4.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Murakami H, Hashizume S, Ohashi H, Shinohara K, Yasumoto K, Nomoto K, Omura H. Human-human hybridomas secreting antibodies specific to human lung carcinoma. In Vitro. Cell Develop Biol. 1985;21:593–596. doi: 10.1007/BF02620891. [DOI] [PubMed] [Google Scholar]
  19. Nussenzweiz M, Shaw A, Sinn E, Danrer D, Holmes K, Morse H, Leder P. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin. Science. 1987;236:816–819. doi: 10.1126/science.3107126. [DOI] [PubMed] [Google Scholar]
  20. Oettinger M, Schatz D, Gorka C, Baltimore D. RAG-1 and RAG-2 adjacent genes that synergistically activate V(D)J recombination. Science. 1990;248:1517–1523. doi: 10.1126/science.2360047. [DOI] [PubMed] [Google Scholar]
  21. Osawa T, Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem. 1987;56:21–36. doi: 10.1146/annurev.bi.56.070187.000321. [DOI] [PubMed] [Google Scholar]
  22. Papavasiliou F, Misulovin Z, Suh H, Nussenzweig M. The role of Igβ inprecursor B cell transition and allele exclution. Science. 1995;268:408–411. doi: 10.1126/science.7716544. [DOI] [PubMed] [Google Scholar]
  23. Schatz D, Oettinger M, Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell. 1989;59:1035–1048. doi: 10.1016/0092-8674(89)90760-5. [DOI] [PubMed] [Google Scholar]
  24. Schatz D, Oettinger M, Schlissel M. V(D)J recombination: Molecular and regulation. Annu Rev Immunol. 1992;10:359–383. doi: 10.1146/annurev.iy.10.040192.002043. [DOI] [PubMed] [Google Scholar]
  25. Stiernholm N, Berinstein N. Up-regulated recombination-activating gene expression in sIg-variants of a human mature B cell line undergoing secondary Igλ rearrangements in cell culture. Eur J Immunol. 1993;23:1501–1504. doi: 10.1002/eji.1830230716. [DOI] [PubMed] [Google Scholar]
  26. Storb U. Transgenic mice with immunologlobulin genes. Annu Rev Immunol. 1987;5:151–174. doi: 10.1146/annurev.iy.05.040187.001055. [DOI] [PubMed] [Google Scholar]
  27. Tachibana H, Seki K, Murakami H. Identification of hybritype carbohydrate chains on the light chain of human monoclonal antibody specific to lung adenocarcinoma. Biochem Biophys Acta. 1993;1182:257–263. doi: 10.1016/0925-4439(93)90067-b. [DOI] [PubMed] [Google Scholar]
  28. Tachibana H, Kido I, Murakami H. Heterogeneous expression of human antibody λ chains by concanavalin A-resistant hybridomas lead to changed antigen binding. J Biol Chem. 1994;269:29061–29066. [PubMed] [Google Scholar]
  29. Tachibana H, Ushio Y, Krungkasem C, Shirahata S. Inducing the loss of immunoglobulin λ light chain production and the rearrangement of a previously excluded allele in human plasma B cell lines with Concanavalin A. J Biol Chem. 1996;271:17404–17410. doi: 10.1074/jbc.271.29.17404. [DOI] [PubMed] [Google Scholar]
  30. Van Gent D, McBlane J, Ramsgen D, Sadofsky M, Hesse J, Gellert M. Initiation of V(D)J recombination in a cell-free system. Cell. 1995;81:925–934. doi: 10.1016/0092-8674(95)90012-8. [DOI] [PubMed] [Google Scholar]
  31. Wamer G, Gaur A, Scott D. A polyclonal model for B-cell tolerance II. Linkage between signaling of B-cell egress from Go, class II upregulation and unresponsiveness. Cell Immunol. 1991;138:404–412. doi: 10.1016/0008-8749(91)90164-7. [DOI] [PubMed] [Google Scholar]
  32. Yancopoulos G, Nolan G, Pollock R, Prockop LS, Henzenberg L, Alt F. A novel fluorescence-based system for assaying and separating live cells according to V(D)J recombinase activity. Mol Cell Biol. 1990;10:1697–1704. doi: 10.1128/mcb.10.4.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cytotechnology are provided here courtesy of Springer Science+Business Media B.V.

RESOURCES